SCZM:NASDAQSantacruz Silver Mining Ltd. Analysis
Data as of 2026-06-28 - not real-time
$6.61
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The stock is trading below its 20‑day and 50‑day moving averages, the MACD histogram is negative and the RSI sits in the low‑mid 40s, all pointing to short‑term bearish momentum. Volatility is extremely high (near 90% over the past month), yet the computed beta is near zero, suggesting the price swings are largely idiosyncratic rather than market‑driven.
Fundamental outlook: Revenue has surged by over 80% year‑over‑year, with solid gross and operating margins, and a healthy return on equity above 30%. The discounted cash‑flow model values the company at roughly $8.20, well above the current $6.60 price, implying substantial upside. The recent publication of the 2025 Sustainability Report underscores a focus on ESG compliance, which may improve stakeholder perception and access to capital.
Fundamental outlook: Revenue has surged by over 80% year‑over‑year, with solid gross and operating margins, and a healthy return on equity above 30%. The discounted cash‑flow model values the company at roughly $8.20, well above the current $6.60 price, implying substantial upside. The recent publication of the 2025 Sustainability Report underscores a focus on ESG compliance, which may improve stakeholder perception and access to capital.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price below short‑term moving averages
- Negative MACD histogram
- High near‑term price volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF implied fair value well above market price
- Strong revenue growth and operating margins
- Undervalued valuation multiples (PE ~10, PB ~3)
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustained growth in silver and zinc assets in Latin America
- Robust balance sheet with low net debt
- Commitment to ESG demonstrated by the 2025 sustainability report
Key Metrics & Analysis
Financial Health
Revenue Growth81.40%
Profit Margin15.96%
P/E Ratio10.2
ROE34.94%
ROA14.84%
Debt/Equity23.36
P/B Ratio2.9
Op. Cash Flow$81.6M
Free Cash Flow$20.6M
Technical Analysis
TrendBearish
RSI41.5
Support$5.88
Resistance$8.49
MA 20$7.07
MA 50$7.98
MA 200$8.52
MACDBearish
VolumeStable
Fear & Greed Index88.55
Valuation
Fair Value$8.21
Target Price$12.00
Upside/Downside81.54%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.02
Volatility89.47%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.